1st Quarter - Amendment
DAVIS & HARMAN LLP for EMERGENT BIOSOLUTIONS, INC.
Firm
Client
Income
$20,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2009 | $20,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 20, 2009 | $20,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the Anthrax vaccine and other biopharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS A DAVIS | — |
Budget/Appropriations BUD
Issues related to the Anthrax vaccine and other biopharmaceutical products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS A DAVIS | — |
Pharmacy PHA
Issues related to Anthrax vaccine and other biopharmaceuticals products.
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS A DAVIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.